Table 2.

General clinical characteristics of long-term BHFS survivors

Clinical characteristicsPatients (%) (total n = 69)
Age, y  
 0-5 29 (42) 
 >5-10 21 (30) 
 >10 18 (26) 
 NA 1 (1) 
Sex  
 M 37 (54) 
 F 25 (36) 
 NA 7 (10) 
GA at birth, wk  
 ≥37 19 (28) 
 30-36 38 (55) 
 <30 9 (13) 
 NA 3 (4) 
First transfusion  
 In utero at GA, wk 41 (59) 
  ≥30 7 (10) 
  20-29 24 (35) 
  <20 2 (3) 
  NA 8 (12) 
 Postnatal 28 (41) 
Current status  
 Transfusion-dependent 53 (77) 
 Transplanted 14 (20) 
 Deceased* 2 (3) 
Clinical characteristicsPatients (%) (total n = 69)
Age, y  
 0-5 29 (42) 
 >5-10 21 (30) 
 >10 18 (26) 
 NA 1 (1) 
Sex  
 M 37 (54) 
 F 25 (36) 
 NA 7 (10) 
GA at birth, wk  
 ≥37 19 (28) 
 30-36 38 (55) 
 <30 9 (13) 
 NA 3 (4) 
First transfusion  
 In utero at GA, wk 41 (59) 
  ≥30 7 (10) 
  20-29 24 (35) 
  <20 2 (3) 
  NA 8 (12) 
 Postnatal 28 (41) 
Current status  
 Transfusion-dependent 53 (77) 
 Transplanted 14 (20) 
 Deceased* 2 (3) 

NA, data not available.

*Both patients suffered from severe developmental delay. One patient died at the age of 11 y owing to pneumonia and respiratory failure.28  The other patient died of fungal infection and severe graft-versus-host disease after HSC transplantation at the age of 13 y (4 mo after transplantation).58 

Close Modal

or Create an Account

Close Modal
Close Modal